USANA to sell segment
This article was originally published in The Rose Sheet
Executive Summary
USANA Health Sciences has signed a letter of intent to sell a business segment of its Draper, Utah-based facility, firm announces June 5. The segment - a third-party contract manufacturing business - reported revenue of $1.95 mil. in the first quarter of 2007, company says. While USANA did not disclose the terms of its transaction, it expects that the sale of the segment will be effective in Q3. The company noted that it will retain the assets associated with its Sensé-brand beauty care and will continue to manufacture those products at its Draper facility, company says. The move is consistent with USANA's long-term objectives, according to USANA President David A. Wentz. "The sale of our third-party contract manufacturing business will allow us to focus 100% of our efforts on growing and expanding our direct selling business," he said in a company release. In May, USANA received a patent for its self-preserving technology (1"The Rose Sheet" May 14, 2007, p. 10)...
You may also be interested in...
USANA Uses Crystals And Antimicrobials, Not Chemicals, To Preserve Product
USANA Health Sciences' self-preserving technology represents a shift away from controversial chemical additives to extend a personal-care product's shelf life
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.